List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #301 to #350.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Oesophageal cancer → Esophageal cancer
- Ofatumumab (Arzzera) → Ofatumumab (Arzerra)
- Olaparib (AZD-2281) → Olaparib (Lynparza)
- Olverembatinib (HQP1351) → Olverembatinib (HQP-1351)
- Omacetaxine mepesuccinate (Omapro) → Omacetaxine (Synribo)
- Omacetaxine mepesuccinate (Synribo) → Omacetaxine (Synribo)
- Ovarian cancer, BRCA-mutated → Ovarian cancer, HRD-positive
- PCI-32765 → Ibrutinib (Imbruvica)
- PCNSL → CNS lymphoma
- PNH → Paroxysmal nocturnal hemoglobinuria
- POEMS → POEMS syndrome
- PTCL → Peripheral T-cell lymphoma
- PTLD → Post-transplant lymphoproliferative disorder
- Pacritinib → Pacritinib (SB1518)
- Pacritinib (SB1518) → Pacritinib (Vonjo)
- Palbociclib (PD-0332991) → Palbociclib (Ibrance)
- Panitumumab → Panitumumab (Vectibix)
- Panobinostat (LBH589) → Panobinostat (Farydak)
- Paroxysmal nocturnal hemoglobinuria (PNH) → Paroxysmal nocturnal hemoglobinuria
- Pediatric Lomustine Dosing Chart → Lomustine (CCNU)
- Peg-asparginase (Oncaspar) → Pegaspargase (Oncaspar)
- Peg-asparginase (Oncospar) → Pegaspargase (Oncaspar)
- Peginterferon alfa-2b (PegIntron) → Peginterferon alfa-2b (Sylatron)
- Penpulimab (AK105) → Penpulimab (Anniko)
- Pertuzumab & Trastuzumab hyaluronidase (Phesgo) → Pertuzumab and Trastuzumab hyaluronidase (Phesgo)
- Pertuzumab (Omnitarg) → Pertuzumab (Perjeta)
- Pimitespib (TAS-116) → Pimitespib (Jeselhy)
- Pirtobrutinib (LOXO-305) → Pirtobrutinib (Jaypirca)
- Plasma cell leukaemia → Plasma cell leukemia
- Platinol → Cisplatin (Platinol)
- Polycythaemia vera → Polycythemia vera
- Pomalidomide (Actimid) → Pomalidomide (Pomalyst)
- Ponatinib (AP24534) → Ponatinib (Iclusig)
- Protamine sulfate → Protamine sulfate (USP)
- Prothrombin Complex Concentrate, Human (Kcentra) → Prothrombin Complex Concentrate, human
- Quizartinib (AC220) → Quizartinib (Vanflyta)
- RCC → Renal cell carcinoma
- RET → Malignant solid neoplasm, RET-mutated
- RRMM → Multiple myeloma, relapsed-refractory
- Radium-223 (Alpharadin) → Radium-223 (Xofigo)
- Radium Ra 223 (Xofigo) → Radium-223 (Xofigo)
- Radotinib (IY5511HCL) → Radotinib (Supect)
- Regorafenib → Regorafenib (Stivarga)
- Regorafenib (BAY 73-4506) → Regorafenib (Stivarga)
- Relatlimab (BMS-986016) → Nivolumab and relatlimab (Opdualag)
- Relugolix (Relumina) → Relugolix (Orgovyx)
- Renal cancer → Renal cell carcinoma
- Revlimid → Lenalidomide (Revlimid)
- Rhabdomyosarcoma - historical → Rhabdomyosarcoma, pediatric - historical
- Rituximab and hyaluronidase human (Rituximab Hycela) → Rituximab and hyaluronidase human (Rituxan Hycela)